Donald F. Farley

Part of Spencer Trask Holdings, Inc., Spencer Trask Specialty Group LLC is a company that provides funding and management resources to assist pharmaceutical ventures. The company is based in New York, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Healthcare Providers Direct, Inc. manufactures medical diagnostic testing equipment. The company was founded in April 2004 and is headquartered in Stone Harbor, NJ.

Healthcare Providers Direct, Inc. manufactures medical diagnostic testing equipment. The company was founded in April 2004 and is headquartered in Stone Harbor, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Healthcare Providers Direct, Inc. manufactures medical diagnostic testing equipment. The company was founded in April 2004 and is headquartered in Stone Harbor, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Healthcare Providers Direct, Inc. manufactures medical diagnostic testing equipment. The company was founded in April 2004 and is headquartered in Stone Harbor, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Healthcare Providers Direct, Inc. manufactures medical diagnostic testing equipment. The company was founded in April 2004 and is headquartered in Stone Harbor, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Minrad International, Inc. develops generic inhalation anesthetics. Its technologies, including its SabreSource system, enable physicians to improve accuracy in surgical procedures, as well as reduce radiation exposure. The company was founded by William H. Burns and is headquartered in Orchard Park, NY.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.